Furosemide and Magnesium glycerophosphate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Furosemide (furosemide) and Magnesium glycerophosphate (magnesium). Common drug interactions include sepsis among females and decreased appetite among males.

The phase IV clinical study analyzes what interactions people have when they take Furosemide and Magnesium glycerophosphate. It is created by eHealthMe based on reports of 60 people who take the same drugs from the FDA, and is updated regularly.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.

What is Magnesium glycerophosphate?

Magnesium glycerophosphate has active ingredients of magnesium. eHealthMe is studying from 428 Magnesium glycerophosphate users. Check the latest studies of Magnesium glycerophosphate.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

60 people who take Furosemide and Magnesium glycerophosphate together, and have interactions are studied.

Furosemide and Magnesium glycerophosphate drug interactions.

What are the common drug interactions of Furosemide and Magnesium Glycerophosphate, by gender? *:

female:

Sepsis (a severe blood infection that can lead to organ failure and death)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Lower respiratory tract infection
Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
Constipation
Neuropathy peripheral (surface nerve damage)
Neutropenia (an abnormally low number of neutrophils)
Peripheral swelling
Back pain
Abdominal pain

male:

Decreased appetite
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Hypernatraemia (an abnormally high plasma concentration of sodium ions)
Influenza
Pneumonia
Asthenia (weakness)
Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
Cardiac failure
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Drug resistance (reduction in effectiveness of a drug)

What are the common drug interactions of Furosemide and Magnesium Glycerophosphate, by age (0-1 to 60+)? *:

0-1:

Hypernatraemia (an abnormally high plasma concentration of sodium ions)
Haematocrit increased
Pulseless electrical activity
Septic shock (shock due to blood infection)
Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)

2-9:

n/a

10-19:

Febrile neutropenia (fever with reduced white blood cells)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Hyperglycaemia (high blood sugar)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
Urinary retention (the inability to completely or partially empty the bladder)
Anaemia (lack of blood)
Toxic encephalopathy (a degenerative neurologic disorder caused by exposure to toxic substances)

20-29:

Haematemesis (vomiting of blood)

30-39:

Photodermatosis (skin disease that is caused by exposure to sunlight)

40-49:

Abdominal pain upper
Body temperature increased
Influenza
Lethargy (tiredness)
Nausea (feeling of having an urge to vomit)
Pneumonia
Pyrexia (fever)
Lower respiratory tract infection
Cough

50-59:

n/a

60+:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Sepsis (a severe blood infection that can lead to organ failure and death)
Upper respiratory tract infection
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Spinal column stenosis (narrowing of spinal column)
Thrombocytopenia (decrease of platelets in blood)
Decreased appetite
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Urinary tract infection
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)

What are the existing conditions these people have? *

Constipation: 31 people, 51.67%
Nausea (feeling of having an urge to vomit): 29 people, 48.33%
Back Pain: 27 people, 45.00%
Pain: 25 people, 41.67%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 24 people, 40.00%
High Blood Pressure: 22 people, 36.67%
Lower Respiratory Tract Infection: 22 people, 36.67%
Indigestion: 21 people, 35.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 21 people, 35.00%
High Blood Cholesterol: 20 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Furosemide and Magnesium glycerophosphate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously